Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 499 entries
View as:

Study on an Optimal Antiviral Treatment in HBeAg Positive Chronic Hepatitis B Patients

Phase: N/A Priority: Normal
NCT ID: NCT03013556 Org: User:
Start: 11/30/16 End: 12/31/21 Due: 12/31/22

Bortezomib for Treating Glomerular Diseases

Phase: N/A Priority: Normal
NCT ID: NCT05383547 Org: User:
Start: 08/02/22 End: 12/31/23 Due: 12/31/24

Chemotherapy Combined With Tislelizumab as Bladder Sparing Option for Patients With Muscle Invasive Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04909775 Org: User:
Start: 07/31/21 End: 07/31/23 Due: 07/31/24

Safety and Efficacy of LPE in Clearing DSA in Patients Who Received Allo-HSCT

Phase: N/A Priority: Normal
NCT ID: NCT06177561 Org: User:
Start: 11/09/23 End: 11/08/25 Due: 11/08/26

Risk Factors and Outcomes in Coronary Chronic Total Occlusion

Phase: N/A Priority: Normal
NCT ID: NCT06137521 Org: User:
Start: 01/01/10 End: 03/01/27 Due: 03/01/28

Controlled Fluid Resuscitation in Sepsis

Phase: N/A Priority: Normal
NCT ID: NCT03214913 Org: User:
Start: 01/01/18 End: 06/30/21 Due: 06/30/22

Genotype-guided Treatment in Newly Diagnosed PTCL

Phase: N/A Priority: Normal
NCT ID: NCT05675813 Org: User:
Start: 02/13/23 End: 07/15/28 Due: 07/15/29

Evaluating Omitting of Internal Mammary Irradiation Among Early Stage Intermediate Risk (N1) Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04517266 Org: User:
Start: 03/01/21 End: 10/30/30 Due: 10/30/31

Systemic Application of Cadonilimab, LM-302, and S-1 Combined With Intraperitoneal Infusion of Paclitaxel for the Treatment of Claudin 18.2-positive Gastric Cancer With Peritoneal Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT06519591 Org: User:
Start: 07/31/24 End: 06/30/26 Due: 06/30/27

Perioperative Treatment of Combined Radiotherapy With SOX, Apatinib and Camrelizumab for Oesophagogastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT07026149 Org: User:
Start: 06/08/25 End: 05/31/30 Due: 05/31/31

IBI343 Combined With Sintilimab Plus Chemotherapy in Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT07025889 Org: User:
Start: 06/02/25 End: 06/30/28 Due: 06/30/29

Autologous Transplantation of Bronchial Basal Cells for Treatment of Bronchiectasis

Phase: N/A Priority: Normal
NCT ID: NCT03655808 Org: User:
Start: 06/21/20 End: 05/17/23 Due: 05/17/24

MT027 Cell Injection in Patients With Advanced Primary or Secondary Peritoneal Tumors

Phase: N/A Priority: Normal
NCT ID: NCT07004647 Org: User:
Start: 03/15/25 End: 11/30/28 Due: 11/30/29

18F FDG and 68Ga FAPI PET/MR Imaging of Carotid Artery Plaque Vulnerability: A Clinical Study in Carotid Artery Plaque Patients

Phase: N/A Priority: Normal
NCT ID: NCT07004673 Org: User:
Start: 04/12/25 End: 12/31/26 Due: 12/31/27

Radiomics in Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05658679 Org: User:
Start: 01/31/16 End: 12/31/24 Due: 12/31/25

Precise Treatment of Prediabetes and Stage 1 Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT04529590 Org: User:
Start: 10/01/20 End: 09/30/23 Due: 09/30/24

Lenalidomide Plus ICE in the Treatment of Refractory and Relapsed DLBCL

Phase: N/A Priority: Normal
NCT ID: NCT03367143 Org: User:
Start: 12/31/16 End: 12/31/20 Due: 12/31/21

Selinexor Combined With R-GDP Regimen for TP53-altered R/R DLBCL

Phase: N/A Priority: Normal
NCT ID: NCT06062641 Org: User:
Start: 10/30/23 End: 09/30/27 Due: 09/30/28

Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT05277688 Org: User:
Start: 03/15/22 End: 12/30/27 Due: 12/30/28

Efficacy and Safety of tACS for Depression: a Multicenter RCT Study

Phase: N/A Priority: Normal
NCT ID: NCT06891326 Org: User:
Start: 10/08/24 End: 10/08/26 Due: 10/08/27

Exploratory Study of Aerosol Inhalation of FB2001 for Post-exposure Prophylaxis of COVID-19 Close Contacts

Phase: N/A Priority: Normal
NCT ID: NCT05415241 Org: User:
Start: 06/09/22 End: 12/31/22 Due: 12/31/23

A Retrospective Study for Nimotuzumab Plus Postoperative Adjuvant Chemotherapy for Resectable Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06363084 Org: User:
Start: 05/01/16 End: 06/30/23 Due: 06/30/24

The Efficacy and Safety of ZR2 Versus R-miniCHOP in the Treatment of Unfit or Frail de Novo Diffuse Large B-cell Lymphoma Patients Aged Older Than or Equal to 70 Years

Phase: N/A Priority: Normal
NCT ID: NCT05179733 Org: User:
Start: 03/02/22 End: 12/25/25 Due: 12/25/26

A Trial on the Recurrence Free Survival Rate of Type I AIP With High-risk of Recurrence

Phase: N/A Priority: Normal
NCT ID: NCT06468709 Org: User:
Start: 06/20/24 End: 07/31/27 Due: 07/31/28

Predictive Role of KLK10 and Other Neuroinflammatory Molecules on Clinical Outcomes of AIS

Phase: N/A Priority: Normal
NCT ID: NCT06549972 Org: User:
Start: 08/12/24 End: 05/31/25 Due: 05/31/26